JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paczkowski, F. A.
Right arrow Articles by Bönisch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paczkowski, F. A.
Right arrow Articles by Bönisch, H.

Vol. 290, Issue 2, 761-767, August 1999

Comparison of the Pharmacological Properties of Cloned Rat, Human, and Bovine Norepinephrine Transporters1

Filip A. Paczkowski, Lesley J. Bryan-Lluka, Peter Pörzgen , Michael Brüss and Heinz Bönisch

Department of Physiology and Pharmacology, The University of Queensland, Brisbane, Queensland, Australia (F.A.P., L.J.B.-L., P.P.) and Department of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (P.P., M.B., H.B.)

The aims of this study were to characterize the recently cloned rat norepinephrine transporter (NET) in more detail and in particular to study possible species differences in its pharmacological properties compared with the human and bovine NETs. The study was carried out by measuring the uptake of [3H]norepinephrine in COS-7 cells expressing the NET after transient transfection with rat, human, or bovine NET cDNA. There were small but significant differences between the rat NET and the human or bovine NETs with respect to the affinities of sodium ions (greater for rat than for bovine) of the substrates norepinephrine, epinephrine, and 1-methyl-4-phenylpyridinium (greater for human than for rat), and of the inhibitor cocaine (greater for human and bovine than for rat), whereas the affinities of dopamine and of most inhibitors, including tricyclic antidepressants, showed no species differences. The fact that the affinities for some substrates, cocaine and sodium ions exhibited small but significant interspecies differences among the rat, human, and bovine NETs suggests that ligand recognition, the translocation process, and sodium ion dependence are influenced differentially by just a few amino acid exchanges in the primary sequences of the transporters. On the other hand, the lack of any major differences in the pharmacological properties of the rat, human, and bovine NETs in this study suggests that data obtained in previous studies on rat tissues and bovine cells can be extrapolated, in all except the most quantitative analyses, to the properties of the human NET.

0022-3565/99/2902-0761$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
D. M. Platt, J. K. Rowlett, and R. D. Spealman
Noradrenergic Mechanisms in Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 894 - 902.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
A. Haunso and D. Buchanan
Pharmacological Characterization of a Fluorescent Uptake Assay for the Noradrenaline Transporter
J Biomol Screen, April 1, 2007; 12(3): 378 - 384.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Pifl, G. Nagy, S. Berenyi, A. Kattinger, H. Reither, and S. Antus
Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 346 - 354.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. I. Damaj, F. I. Carroll, J. B. Eaton, H. A. Navarro, B. E. Blough, S. Mirza, R. J. Lukas, and B. R. Martin
Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors
Mol. Pharmacol., September 1, 2004; 66(3): 675 - 682.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. A. Sharpe, E. Palant, C. I. Schroeder, D. M. Kaye, D. J. Adams, P. F. Alewood, and R. J. Lewis
Inhibition of the Norepinephrine Transporter by the Venom Peptide {chi}-MrIA: SITE OF ACTION, Na+ DEPENDENCE, AND STRUCTURE-ACTIVITY RELATIONSHIP
J. Biol. Chem., October 10, 2003; 278(41): 40317 - 40323.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. J. Bryan-Lluka, H. Bonisch, and R. J. Lewis
{chi}-Conopeptide MrIA Partially Overlaps Desipramine and Cocaine Binding Sites on the Human Norepinephrine Transporter
J. Biol. Chem., October 10, 2003; 278(41): 40324 - 40329.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.